ABCL vs REGN: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and REGN in 2026
ABCL
Abcellera Biologics Inc
$5.73
REGN
REGN
—
Key Metrics Comparison
| Metric | ABCL | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.95B | N/A | ABCL |
| P/E Ratio | N/A | N/A | Tie |
| EPS (TTM) | $N/A | $N/A | ABCL |
| Revenue Growth | 1.0% | 0.0% | ABCL |
| Gross Margin | -135.9% | 0.0% | ABCL |
Analyze ABCL
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or REGN a better investment?
Comparing ABCL and REGN: Abcellera Biologics Inc has a market cap of $1.95B while REGN has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and REGN?
ABCL (Abcellera Biologics Inc) and REGN (REGN) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or REGN?
ABCL has higher revenue growth at 1.0% vs 0.0% for REGN.
Which company is more profitable: ABCL or REGN?
REGN (REGN) has higher gross margins at 0.0% compared to -135.9% for ABCL.
Which is the larger company: ABCL or REGN?
Abcellera Biologics Inc (ABCL) is larger with a market cap of $1.95B compared to N/A for REGN.
Should I buy ABCL or REGN in 2026?
Both ABCL and REGN have investment merit. ABCL trades at $5.73 while REGN trades at $N/A. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and REGN stock?
Key differences: Market Cap ($1.95B vs N/A), P/E Ratio (N/A vs N/A), Revenue Growth (1.0% vs 0.0%), Gross Margin (-135.9% vs 0.0%).
Should I buy ABCL or REGN in 2026?
The choice between ABCL and REGN depends on your investment goals. ABCL shows higher revenue growth (1.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and REGN?
ABCL (Abcellera Biologics Inc) has a market cap of $1.95B, while REGN (REGN) has a market cap of N/A. ABCL is the larger company by market value.